SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-569611
Filing Date
2016-04-29
Accepted
2016-04-29 16:45:05
Documents
4
Period of Report
2016-07-14
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d183536ddef14a.htm DEF 14A 329537
2 GRAPHIC g183536002pc.jpg GRAPHIC 4117
3 GRAPHIC g183536g48k66.jpg GRAPHIC 32373
4 GRAPHIC g183536g70d41.jpg GRAPHIC 25648
  Complete submission text file 0001193125-16-569611.txt   416430
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEF 14A | Act: 34 | File No.: 001-37695 | Film No.: 161607481
SIC: 2834 Pharmaceutical Preparations